Purchases and Sales Made in Q4 2021 in Vaxcyte, Inc. (PCVX)
This table provides information about the institutional ownership of Vaxcyte, Inc. (PCVX) during Q4 2021. The information is specifically focused on institutions that hold shares of Vaxcyte, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 07, 2022
Q4 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Jan 20, 2022
Q4 2021
|
Parallel Advisors, LLC
|
SELL
|
- |
-28Closed |
$541 - $741
|
0
$0
|
|
|
Feb 08, 2022
Q4 2021
|
Pro Share Advisors LLC
|
SELL
|
- |
-72- 0.44% |
$1.39K - $1.9K
|
16.3K
$1.44M
|
|
|
Feb 02, 2022
Q4 2021
|
New York State Common Retirement Fund
|
SELL
|
- |
-105- 0.37% |
$2.03K - $2.78K
|
28.6K
$2.53M
|
|
|
Feb 14, 2022
Q4 2021
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-139- 1.68% |
$2.69K - $3.68K
|
8.12K
$717K
|
|
|
Feb 10, 2022
Q4 2021
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-536- 1.13% |
$10.4K - $14.2K
|
46.9K
$4.15M
|
|
|
Feb 11, 2022
Q4 2021
|
American International Group, Inc.
New York, NY |
SELL
|
- |
-643- 2.91% |
$12.4K - $17K
|
21.5K
$1.9M
|
|
|
Feb 14, 2022
Q4 2021
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-800- 6.46% |
$15.5K - $21.2K
|
11.6K
$1.02M
|
|
|
Feb 11, 2022
Q4 2021
|
Macquarie Group LTD
Australia, C3 |
SELL
|
- |
-1.06K- 53.41% |
$20.6K - $28.1K
|
928
$82K
|
|
|
Feb 15, 2022
Q4 2021
|
Penserra Capital Management LLC
Orinda, CA |
SELL
|
- |
-1.2KClosed |
$23.1K - $31.6K
|
0
$0
|
|
|
Feb 11, 2022
Q4 2021
|
Quantbot Technologies LP
New York, NY |
SELL
|
- |
-1.5K- 45.45% |
$29K - $39.7K
|
1.8K
$159K
|
|
|
Feb 14, 2022
Q4 2021
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-2.19K- 13.13% |
$42.3K - $57.9K
|
14.5K
$1.28M
|
|
|
Feb 14, 2022
Q4 2021
|
ETF Managers Group, LLC
Summit, NJ |
SELL
|
- |
-3.1K- 16.28% |
$59.9K - $82K
|
16K
$1.41M
|
|
|
Feb 08, 2022
Q4 2021
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-3.65K- 0.97% |
$70.4K - $96.4K
|
371K
$32.8M
|
|
|
Feb 10, 2022
Q4 2021
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-5.66K- 21.7% |
$109K - $150K
|
20.4K
$1.8M
|
|
|
Feb 09, 2022
Q4 2021
|
Principal Financial Group Inc
Des Moines, IA |
SELL
|
- |
-10.1KClosed |
$196K - $268K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-10.6K- 6.95% |
$206K - $281K
|
142K
$12.6M
|
|
|
Feb 11, 2022
Q4 2021
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-14.3KClosed |
$276K - $378K
|
0
$0
|
|
|
Feb 07, 2022
Q4 2021
|
Sg Americas Securities, LLC
|
SELL
|
- |
-15.5K- 60.44% |
$300K - $410K
|
10.2K
$897K
|
|
|
Jun 21, 2023
Q4 2021
|
Met Life Investment Management, LLC
Whippany, NJ |
SELL
|
- |
-22.6K- 60.22% |
$437K - $599K
|
14.9K
$1.32M
|
|
|
Feb 14, 2022
Q4 2021
|
Opaleye Management Inc.
Boston, MA |
SELL
|
- |
-37.6K- 10.64% |
$726K - $995K
|
316K
$27.9M
|
|
|
Feb 14, 2022
Q4 2021
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-47.8K- 19.41% |
$924K - $1.26M
|
198K
$17.5M
|
|
|
Feb 11, 2022
Q4 2021
|
Affinity Asset Advisors, LLC
New York, NY |
SELL
|
- |
-50KClosed |
$966K - $1.32M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-60.9K- 17.12% |
$1.18M - $1.61M
|
295K
$26M
|
|
|
Feb 14, 2022
Q4 2021
|
Sabby Management, LLC
Upper Saddle River, NJ |
SELL
|
- |
-66.5KClosed |
$1.28M - $1.76M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Ubs Group Ag
|
SELL
|
- |
-76.6K- 62.86% |
$1.48M - $2.02M
|
45.2K
$4M
|
|
|
Feb 14, 2022
Q4 2021
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
SELL
|
- |
-294K- 20.91% |
$5.68M - $7.77M
|
1.11M
$98.2M
|